PSG — PharmaSGP Holding SE Cashflow Statement
0.000.00%
Last trade - 00:00- €368.40m
- €400.59m
- €118.84m
- 98
- 24
- 87
- 85
Annual cashflow statement for PharmaSGP Holding SE, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 10.6 | 10.7 | 12 | 16.4 | 19.5 |
| Depreciation | |||||
| Non-Cash Items | 0.157 | 0.907 | 4.08 | 4.43 | 4.14 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 4.17 | -2.93 | -0.571 | -3.56 | -8.21 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 15.5 | 12.2 | 24.7 | 26.6 | 24.9 |
| Capital Expenditures | -0.898 | -83.5 | -0.787 | -0.866 | -1.47 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0 | — | — | — | — |
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -0.898 | -83.5 | -0.787 | -0.866 | -1.47 |
| Financing Cash Flow Items | -94.8 | -0.643 | -1.8 | -2.99 | -2.48 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -95 | 84 | -12.1 | -17.6 | -37.7 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -80.5 | 12.8 | 11.8 | 8.12 | -14.3 |